TERM ID="NYU_TERM_1" STRING="(HPV16)-associated tumors" FREQUENCY=1 START=76 END=101 LEMMA="(HPV16)-ASSOCIATED TUMOR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_2" STRING="Therapeutic strategies" FREQUENCY=1 START=322 END=344 LEMMA="THERAPEUTIC STRATEGY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_3" STRING="adjuvant administration" FREQUENCY=1 START=1183 END=1206 LEMMA="ADJUVANT ADMINISTRATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_4" STRING="adjuvant immunotherapeutic modalities" FREQUENCY=1 START=1715 END=1752 LEMMA="ADJUVANT IMMUNOTHERAPEUTIC MODALITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_5" STRING="adjuvant treatment" FREQUENCY=1 START=103 END=121 LEMMA="ADJUVANT TREATMENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_6" STRING="administration" FREQUENCY=1 START=1393 END=1407 LEMMA="ADMINISTRATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_7" STRING="cancer patients" FREQUENCY=1 START=575 END=590 LEMMA="CANCER PATIENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_8" STRING="cellular vaccines" FREQUENCY=4 START=21 END=38 LEMMA="CELLULAR VACCINE" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_9" STRING="cellular vaccines" FREQUENCY=4 START=501 END=518 LEMMA="CELLULAR VACCINE" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_10" STRING="cellular vaccines" FREQUENCY=4 START=950 END=967 LEMMA="CELLULAR VACCINE" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_11" STRING="cellular vaccines" FREQUENCY=4 START=1432 END=1449 LEMMA="CELLULAR VACCINE" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_12" STRING="conventional therapeutic modalities" FREQUENCY=1 START=1127 END=1162 LEMMA="CONVENTIONAL THERAPEUTIC MODALITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_13" STRING="defence effectors" FREQUENCY=1 START=729 END=746 LEMMA="DEFENCE EFFECTOR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_14" STRING="experimental model" FREQUENCY=1 START=1596 END=1614 LEMMA="EXPERIMENTAL MODEL" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_15" STRING="experimental model of murine tumors" FREQUENCY=1 START=1596 END=1631 LEMMA="MURINE TUMOR EXPERIMENTAL MODEL" LEMMA_FREQUENCY=1 HEAD_TERM="experimental model" HEAD_LEMMA="EXPERIMENTAL MODEL"
TERM ID="NYU_TERM_16" STRING="experimental model of murine tumors mimicking human HPV16-associated neoplasms" FREQUENCY=1 START=1596 END=1674 LEMMA="MIMICKING HUMAN HPV16-ASSOCIATED NEOPLASM MURINE TUMOR EXPERIMENTAL MODEL" LEMMA_FREQUENCY=1 HEAD_TERM="mimicking human HPV16-associated neoplasms" HEAD_LEMMA="MIMICKING HUMAN HPV16-ASSOCIATED NEOPLASM"
TERM ID="NYU_TERM_17" STRING="experimental models" FREQUENCY=1 START=1018 END=1037 LEMMA="EXPERIMENTAL MODEL" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_18" STRING="genome" FREQUENCY=1 START=400 END=406 LEMMA="GENOME" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_19" STRING="genome of tumor cells" FREQUENCY=1 START=400 END=421 LEMMA="TUMOR CELL GENOME" LEMMA_FREQUENCY=1 HEAD_TERM="genome" HEAD_LEMMA="GENOME"
TERM ID="NYU_TERM_20" STRING="immunostimulatory genes" FREQUENCY=1 START=367 END=390 LEMMA="IMMUNOSTIMULATORY GENE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_21" STRING="immunosuppressive" FREQUENCY=1 START=1479 END=1496 LEMMA="IMMUNOSUPPRESSIVE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_22" STRING="immunosuppressive immunocyte subsets" FREQUENCY=1 START=1268 END=1304 LEMMA="IMMUNOSUPPRESSIVE IMMUNOCYTE SUBSET" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_23" STRING="metastases" FREQUENCY=1 START=917 END=927 LEMMA="METASTAS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_24" STRING="micrometastases" FREQUENCY=1 START=268 END=283 LEMMA="MICROMETASTAS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_25" STRING="mimicking human HPV16-associated neoplasms" FREQUENCY=1 START=1632 END=1674 LEMMA="MIMICKING HUMAN HPV16-ASSOCIATED NEOPLASM" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_26" STRING="modified vaccines" FREQUENCY=1 START=1222 END=1239 LEMMA="MODIFIED VACCINE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_27" STRING="murine tumors" FREQUENCY=1 START=1618 END=1631 LEMMA="MURINE TUMOR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_28" STRING="oncology" FREQUENCY=1 START=312 END=320 LEMMA="ONCOLOGY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_29" STRING="papillomavirus type" FREQUENCY=1 START=53 END=72 LEMMA="PAPILLOMAVIRUS TYPE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_30" STRING="potential prospect" FREQUENCY=1 START=535 END=553 LEMMA="POTENTIAL PROSPECT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_31" STRING="primary tumors" FREQUENCY=1 START=823 END=837 LEMMA="PRIMARY TUMOR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_32" STRING="residual disease" FREQUENCY=2 START=133 END=149 LEMMA="RESIDUAL DISEASE" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_33" STRING="residual disease" FREQUENCY=2 START=1543 END=1559 LEMMA="RESIDUAL DISEASE" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_34" STRING="surgery/chemotherapy Local recurrences" FREQUENCY=1 START=156 END=194 LEMMA="SURGERY/CHEMOTHERAPY LOCAL RECURRENCE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_35" STRING="tumor cells" FREQUENCY=1 START=410 END=421 LEMMA="TUMOR CELL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_36" STRING="tumor resection" FREQUENCY=1 START=210 END=225 LEMMA="TUMOR RESECTION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_37" STRING="tumor-bearing patients" FREQUENCY=1 START=1045 END=1067 LEMMA="TUMOR-BEARING PATIENT" LEMMA_FREQUENCY=1
